Cybin Inc.
Cybin Inc. (CYBN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CYBN · as of Jun 9, 2026
Key Statistics
Explore Cybin Inc. Data
cybn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 100.0%
Competitors & Peers
cybn competitorsCYBN
ALEC
IMDX
IPHA
MIST
MOLNStock Performance
Full HistoryAbout Cybin Inc.
Cybin Inc. is a biopharmaceutical firm dedicated to pioneering treatments that leverage psychedelic compounds. Its research and development portfolio encompasses several key candidates: CYB003, a modi…
what is cybin inc. · cybn stock overview · cybin inc. company profile · who is cybin inc. ceo · cybn AMEX · cybin inc. headquarters · cybin inc. business segments
About Stock Overview & Key Data
Cybin Inc. (CYBN) is a Healthcare company in the Biotechnology industry, listed on AMEX since Sep 13, 2019. As of the latest trading session, CYBN stock price is $8.28, with a market capitalization of $413.0M. The stock has returned -15.85% over the past 12 months and +0.00% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Cybin Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Cybin Inc. reported revenue of — and net income of -$113.1M. For detailed data — including Cybin Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Cybin Inc. (CYBN) stock price is $8.28. The stock is traded on AMEX under the ticker symbol CYBN. The 52-week range is $4.81 – $10.72.